Literature DB >> 2267963

Automated flow cytometric analysis of drug susceptibility of malaria parasites.

P H van Vianen1, S Thaithong, P P Reinders, A van Engen, M van der Keur, H J Tanke, H J van der Kaay, B Mons.   

Abstract

A method is described for the fully automated reading of Plasmodium falciparum drug susceptibility tests. Cultured material was fixed and could be stored for greater than or equal to 6 months until analysis. The parasites were stained for DNA with the fluorescent dye Hoechst 33258 and analyzed by flow cytometry. The procedure was done in 96-well microtiter plates, after which the material was directed through the sensing region in the flow cytometer. The data resulting from the analysis were stored by microcomputer and processed by a program developed for this purpose. Using this method, a number of different parameters describing the growth in culture can be assessed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2267963     DOI: 10.4269/ajtmh.1990.43.602

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  11 in total

Review 1.  Methodology and application of flow cytometry for investigation of human malaria parasites.

Authors:  Brian T Grimberg
Journal:  J Immunol Methods       Date:  2011-02-04       Impact factor: 2.303

Review 2.  Applications of flow cytometry to clinical microbiology.

Authors:  A Alvarez-Barrientos; J Arroyo; R Cantón; C Nombela; M Sánchez-Pérez
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

3.  Susceptibility of an emetine-resistant mutant of Entamoeba histolytica to multiple drugs and to channel blockers.

Authors:  J C Samuelson; A Burke; J M Courval
Journal:  Antimicrob Agents Chemother       Date:  1992-11       Impact factor: 5.191

4.  Flow cytometric readout based on Mitotracker Red CMXRos staining of live asexual blood stage malarial parasites reliably assesses antibody dependent cellular inhibition.

Authors:  Prajakta S Jogdand; Susheel K Singh; Michael Christiansen; Morten H Dziegiel; Subhash Singh; Michael Theisen
Journal:  Malar J       Date:  2012-07-20       Impact factor: 2.979

Review 5.  Development in Assay Methods for in Vitro Antimalarial Drug Efficacy Testing: A Systematic Review.

Authors:  Shweta Sinha; Phulen Sarma; Rakesh Sehgal; Bikash Medhi
Journal:  Front Pharmacol       Date:  2017-10-23       Impact factor: 5.810

Review 6.  Drug susceptibility testing methods of antimalarial agents.

Authors:  Ardhendu K Maji
Journal:  Trop Parasitol       Date:  2018-12-27

7.  A comparative study of a flow-cytometry-based assessment of in vitro Plasmodium falciparum drug sensitivity.

Authors:  Stephan Karl; Rina Pm Wong; Tim G St Pierre; Timothy Me Davis
Journal:  Malar J       Date:  2009-12-14       Impact factor: 2.979

8.  Comparison between Flow Cytometry, Microscopy, and Lactate Dehydrogenase-Based Enzyme-Linked Immunosorbent Assay for Plasmodium falciparum Drug Susceptibility Testing under Field Conditions.

Authors:  Charles J Woodrow; Chirapat Wangsing; Kanlaya Sriprawat; Peter R Christensen; Francois Nosten; Laurent Rénia; Bruce Russell; Benoît Malleret
Journal:  J Clin Microbiol       Date:  2015-08-12       Impact factor: 5.948

9.  Quantification of Plasmodium ex vivo drug susceptibility by flow cytometry.

Authors:  Grennady Wirjanata; Irene Handayuni; Pak Prayoga; Dwi Apriyanti; Ferryanto Chalfein; Boni F Sebayang; Steven Kho; Rintis Noviyanti; Enny Kenangalem; Brice Campo; Jeanne Rini Poespoprodjo; Ric N Price; Jutta Marfurt
Journal:  Malar J       Date:  2015-10-24       Impact factor: 2.979

Review 10.  Amazonian plant natural products: perspectives for discovery of new antimalarial drug leads.

Authors:  Adrian Martin Pohlit; Renata Braga Souza Lima; Gina Frausin; Luiz Francisco Rocha E Silva; Stefanie Costa Pinto Lopes; Carolina Borsoi Moraes; Pedro Cravo; Marcus Vinícius Guimarães Lacerda; André Machado Siqueira; Lucio H Freitas-Junior; Fabio Trindade Maranhão Costa
Journal:  Molecules       Date:  2013-08-02       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.